← Back to Search

Telehealth for Lewy Body Dementia

N/A
Recruiting
Led By Bhavana Patel, DO
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial found that delivering care for Lewy body dementia remotely using video technology was effective and improved access to care for patients.

Who is the study for?
This trial is for people with Lewy Body Dementia (LBD), which includes some Parkinson's disease symptoms. Participants need a specialist-confirmed LBD diagnosis, mild to moderate dementia, and internet access with Zoom. They must speak English and have a caregiver at home willing to join the study. Healthcare professionals involved should have over a year of experience with LBD.
What is being tested?
The trial is testing 'Tele-neurohub', a video technology system designed to deliver interdisciplinary care remotely to patients with LBD, aiming to improve their access to specialist care without needing to travel.
What are the potential side effects?
Since this intervention involves telehealth services rather than medication or invasive procedures, side effects are not typical in the medical sense but may include technical difficulties or discomfort using video technology.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of completed tele-health visits
Secondary study objectives
Appropriateness assessed by Intervention Appropriateness Measure
Satisfaction assessed by Patient Assessment of Communication of Telehealth questionnaire.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Tele-neurohubExperimental Treatment1 Intervention
This group will receive the tele-neurohub intervention which includes telemedicine appointments with the neurologist, speech therapist, social worker, and nutritionist at baseline, 3 months and 6 months, and PT and OT every 2 weeks for maintenance neuro-rehabilitation.
Group II: Usual care groupActive Control1 Intervention
Receive usual care but will have study visit assessments at baseline and 6 months.

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,401 Previous Clinical Trials
766,903 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,789 Previous Clinical Trials
28,188,226 Total Patients Enrolled
Bhavana Patel, DOPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
60 Total Patients Enrolled

Media Library

Tele-neurohub Clinical Trial Eligibility Overview. Trial Name: NCT05014971 — N/A
Lewy Body Dementia Research Study Groups: Usual care group, Tele-neurohub
Lewy Body Dementia Clinical Trial 2023: Tele-neurohub Highlights & Side Effects. Trial Name: NCT05014971 — N/A
Tele-neurohub 2023 Treatment Timeline for Medical Study. Trial Name: NCT05014971 — N/A
~37 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top